1. Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study 
M. Søgaard, U. Heide-Jørgensen, J.P. Vandenbroucke, H.C. Schønheyder, C.M.J.E. Vandenbroucke-Grauls 
Clinical Microbiology and Infection 
Volume 23, Issue 12, Pages (December 2017)
DOI: /j.cmi
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Risk of extended spectrum β-lactamase (ESBL) associated with previous exposure to systemic antibiotics compared with (a) controls with non-ESBL Escherichia coli urinary tract infection, and (b) general population controls. Antibiotic exposure include all reimbursed antibiotics dispensed from pharmacies in the region, whereas in-hospital antibiotic exposure is not included.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
Risk of extended spectrum β-lactamase (ESBL) associated with previous hospitalization compared with controls with non-ESBL Escherichia coli urinary tract infection.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

4. Fig. 3
Risk of extended spectrum β-lactamase (ESBL) associated with surgical procedures except skin and soft tissue compared with controls with non-ESBL Escherichia coli urinary tract infection.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions